CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $380K invested in Can-Fite BioPharma in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

18% less capital invested

Capital invested by funds: $465K → $380K (-$84.3K)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11K
2
+$9.84K
3
+$7.37K

Top Sellers

1
-$21.1K
2
-$14K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$247K
2
$46K
3
$23K
4
$22K
5
$13K
6
$11K
7
$9K
8
$4K
9
$4K
10
$847
11
$410
12
$199
13
–